Skip to content

Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication

Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04982822
Enrollment
314
Registered
2021-07-29
Start date
2020-12-01
Completion date
2024-01-31
Last updated
2024-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery, Urologic Diseases

Keywords

Urology, Senhance, Robotic surgical system, Laparoscopic surgery

Brief summary

An observational study to collect data from the participants who received urologic surgeries using the Senhance Robotic system.

Detailed description

This is an observational study and investigators will collect peri-operative demographic data, and short-term outcomes (3-6 months) from the participants who received minimal invasive surgeries using Senhance robotic system in the National Taiwan University Hospital Yunlin Branch, Urology Department. The investigators want to demonstrate if the robotic system is safe and feasible in urologic laparoscopic surgeries. The operation included TEP, radical prostatectomy, radical nephrectomy (nephroureterectomy) , adrenalectomy, radical cystectomy, and ureter surgery et al. up to 2022/12, we had recruited 127 TEP, 83 radical prostatectomies, 17 adrenalectomies, 40 nephrectomies, 29 partial nephrectomies, 13 radical cystectomies and 18 other surgeries, such as ureter surgery

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

Patients undergo laparoscopic urologic surgeries

Design outcomes

Primary

MeasureTime frameDescription
Peri-operative complicationspostoperative 30 daysUsing Clavien-Dindo classification to record the safety outcome
short-term outcome3-6 monthsthe short-term outcome was according to a different surgery, such as post-operative 3 months PSA, incontinence rate in radical prostatectomy,

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026